Cell-based in vitro kits for drug discovery
Easing your Screening
The leading manufacturer of ready-to-use cell culture plates
Everyday solutions for your in vitro ADME-Tox needs
Permeability Tools
Transporter Drug Interactions
Blood Brain Barrier
ReadyCell facilitates and streamlines drug discovery and development study assays with readily available kits that are stored and transported at room temperature.
Pre-Plated Products
Our cell-based ready-to-use kits maximize efficacy and safety testing of active molecules as an alternative to animal testing for drug discovery.
Worldwide Shipping
Thanks to our innovative and patented Shipping Medium, a gel-like preservation matrix, we send cells at room temperature around the globe.
Cost-Saving Assays
Allow your business to respond better to market needs, have a reliable provider of high-quality cell kits, and reduce your capital expenditure.
Do you want to know more about ReadyCell?
Discover our innovative monolayer ADME in vitro assay tools plus efflux and absorption transporters and toxicity metabolism.
Stretchbio holds a meeting in Denmark to evaluate the first 12 months of the project
Readycell participated in the annual meeting of the StretchBio Project, which was held at the Danmarks Tekniske Universitet (DTU) in Copenhagen.
A new study uses CacoGoblet in a gut-liver-organ-on-a-chip
An investigation led by the researcher Nicoló Milani was published in the prestigious analytical journal Lab on a Chip. The CacoGoblet kit was employed to investigate the permeability and the metabolism of the compound in a gut-liver-organ-on-a-chip (OoC).
Caco-2 Permeability Assay Protocol
Caco-2 cells assay is a reference assayto evaluate intestinal permeability in drug discovery stages, optimizing novel compounds screening.
ReadyCell is attending the 4th Brain Barriers Summit in Boston
Our ReadyCell sales representative Carla Sapienza will travel next August 29th, 30th and 31st to Boston to attend the Brain Barriers Summit, an event that aims to join industry experts through a discursive forum and evaluate how neuropharmaceuticals can be targeted.